Skip to main content
Clinical Trials/CTRI/2024/05/067894
CTRI/2024/05/067894
Not yet recruiting
Phase 3

To Evaluate the Efficacy of Add on Treatment of Oral Drug Formulation with Agnikarma in the Management of Jaanu Sandhigata Vata W.S.R. to Osteoarthritis of Knee Joint - A Randomized Controlled Trial. - NI

CCRAS, PG - STAR0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
CCRAS, PG - STAR
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
CCRAS, PG - STAR

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosed cases of Jaanu Sandhigata vata (Osteoarthritisof knee joint) will be selected irrespective of gender, Socioeconomic status, Religion and Occupation.
  • 2\.Jaanu Sandhigata Vata (Osteoarthritis of knee joint\- Unilateral or bilateral).
  • 3\. Kellgren and Lawrence Classification System of Osteoarthritis (Grade 0,1,2,3\).

Exclusion Criteria

  • 1\.The patients of infective, neoplastic and Traumatic injuries of knee joint.
  • 2\.Patients who have received intra articular corticosteroids,Post surgical and Obese individuals.
  • 3\.Patients suffering from Hypertension, Diabetes Mellitus, Rheumatoid Arthritis, Systemic Lupus Erythmatous and Other Systemic disorders.
  • 4\.Pregnant and Lactating women.
  • 5\.Patients who are contra indicated for Agnikarma.

Outcomes

Primary Outcomes

Not specified

Similar Trials